Arch Venture Corp »

Phoenix Biotech Acquisition Class A shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2024-06-30 $432k 1.4M 0.30
2024-03-31 $4.4M 1.4M 3.07

More positions owned by Arch Venture Corp

Beam Therapeutics (BEAM)
Rapport Therapeutics (RAPP)
Erasca (ERAS)
Verve Therapeutics (VERV)
Gossamer Bio (GOSS)
Q32 Bio (QTTB)
Unity Biotechnology Com New (UBX)
Singular Genomics Systems Com New (OMIC)
Cero Therapeutics Holdings Class A Com (CERO)

View all positions for Arch Venture Corp

Top funds holding Phoenix Biotech Acquisition Class A

Arch Venture Corp
Arena Investors
Geode Capital Management
Honkamp Krueger Financial Services
Hrt Financial
Fifth Lane Capital
Jane Street
FNY Investment Advisers
Two Sigma Investments
CI Private Wealth
Birchview Capital
Jump Financial
Advisor Group Holdings
Pineridge Advisors
Bank of America Corporation

View all funds holding Phoenix Biotech Acquisition Class A